Eastern Link Capital

About The Fund

Eastern Link Capital (ELC) is a China-focused private equity fund with registration under the Asset Management Association of China (AMAC). ELC specializes in investing in late-stage companies and facilitates middle market buyouts across sectors such as consumer, healthcare services & medical devices, and technology. Their investment strategy capitalizes on their partners' hands-on experience with China's local capital markets, aiming to assist portfolio companies to navigate and leverage the dynamic financial landscape in China, ultimately generating significant returns for their investors. ELC is well-known for its strong local access to China's capital markets, which is a cornerstone of its investment methodology. The fund manages a substantial amount of capital, sourced from leading institutional investors that include the prestigious joint venture fund of China Development Bank and Suzhou Industrial Park, Beijing Municipal Government Guidance Fund, and China Create Capital. ELC's targeted investments typically look for high-growth companies aspiring to expand revenue and accelerate profitability. They prioritize firms with excellent executive teams, scalable business models, a growing customer base, attractive market growth, significant profitability potential, and clear exit strategies within a three to five-year timeframe. Ideal investment candidates are also expected to achieve a top 5 market position and have annual revenues of $500 million or more. As for investment exit strategies, ELC focuses on opportunities that may culminate in an IPO or M&A events with financial or strategic buyers. ELC's presence extends beyond Beijing, with additional offices located in Suzhou, Boston, and Seattle. They maintain a diversified investment portfolio with companies like Yuanxing Gene-Tech, GO HEALTH, SINOPharm Animal Health, and several other enterprises across their strategic sectors.